BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28624529)

  • 1. Cyclopamine sensitizes TRAIL-resistant gastric cancer cells to TRAIL-induced apoptosis via endoplasmic reticulum stress-mediated increase of death receptor 5 and survivin degradation.
    Na YJ; Lee DH; Kim JL; Kim BR; Park SH; Jo MJ; Jeong S; Kim HJ; Lee SY; Jeong YA; Oh SC
    Int J Biochem Cell Biol; 2017 Aug; 89():147-156. PubMed ID: 28624529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
    Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
    Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thioridazine Sensitizes Apoptotic Effect of TRAIL in Human Lung Cancer PC9 Cells Through ER Stress Mediated Up-regulation of DR5].
    Li J; Wang Y; Liu L; Yuan Y; Bao Y
    Zhongguo Fei Ai Za Zhi; 2017 Feb; 20(2):80-87. PubMed ID: 28228218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
    Tse AK; Chow KY; Cao HH; Cheng CY; Kwan HY; Yu H; Zhu GY; Wu YC; Fong WF; Yu ZL
    J Biol Chem; 2013 Oct; 288(41):29923-33. PubMed ID: 23986445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indomethacin sensitizes TRAIL-resistant melanoma cells to TRAIL-induced apoptosis through ROS-mediated upregulation of death receptor 5 and downregulation of survivin.
    Tse AK; Cao HH; Cheng CY; Kwan HY; Yu H; Fong WF; Yu ZL
    J Invest Dermatol; 2014 May; 134(5):1397-1407. PubMed ID: 24213373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L; Zongyuan Y; Cheng G; Lingyun Z; Guilian Y; Wei G
    Cancer Sci; 2014 May; 105(5):520-7. PubMed ID: 24612139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guggulsterone sensitizes hepatoma cells to TRAIL-induced apoptosis through the induction of CHOP-dependent DR5: involvement of ROS-dependent ER-stress.
    Moon DO; Park SY; Choi YH; Ahn JS; Kim GY
    Biochem Pharmacol; 2011 Dec; 82(11):1641-50. PubMed ID: 21903093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of euchromatin histone-lysine N-methyltransferase 2 sensitizes breast cancer cells to tumor necrosis factor-related apoptosis-inducing ligand through reactive oxygen species-mediated activating transcription factor 4-C/EBP homologous protein-death receptor 5 pathway activation.
    Kim SY; Hong M; Heo SH; Park S; Kwon TK; Sung YH; Oh Y; Lee S; Yi GS; Kim I
    Mol Carcinog; 2018 Nov; 57(11):1492-1506. PubMed ID: 29964331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L; Meng Y; Sun Q; Zhang Z; Guo X; Sheng X; Tai G; Cheng H; Zhou Y
    Cell Death Dis; 2016 Aug; 7(8):e2334. PubMed ID: 27512955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thapsigargin sensitizes human esophageal cancer to TRAIL-induced apoptosis via AMPK activation.
    Ma Z; Fan C; Yang Y; Di S; Hu W; Li T; Zhu Y; Han J; Xin Z; Wu G; Zhao J; Li X; Yan X
    Sci Rep; 2016 Oct; 6():35196. PubMed ID: 27731378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
    Gupta SC; Francis SK; Nair MS; Mo YY; Aggarwal BB
    J Biol Chem; 2013 Nov; 288(45):32343-32356. PubMed ID: 24078627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monensin, a polyether ionophore antibiotic, overcomes TRAIL resistance in glioma cells via endoplasmic reticulum stress, DR5 upregulation and c-FLIP downregulation.
    Yoon MJ; Kang YJ; Kim IY; Kim EH; Lee JA; Lim JH; Kwon TK; Choi KS
    Carcinogenesis; 2013 Aug; 34(8):1918-28. PubMed ID: 23615398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casticin potentiates TRAIL-induced apoptosis of gastric cancer cells through endoplasmic reticulum stress.
    Zhou Y; Tian L; Long L; Quan M; Liu F; Cao J
    PLoS One; 2013; 8(3):e58855. PubMed ID: 23536831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Verrucarin A sensitizes TRAIL-induced apoptosis via the upregulation of DR5 in an eIF2α/CHOP-dependent manner.
    Moon DO; Asami Y; Long H; Jang JH; Bae EY; Kim BY; Choi YH; Kang CH; Ahn JS; Kim GY
    Toxicol In Vitro; 2013 Feb; 27(1):257-63. PubMed ID: 22982206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-methoxy-5-amino-N-hydroxybenzamide sensitizes colon cancer cells to TRAIL-induced apoptosis by regulating death receptor 5 and survivin expression.
    Stolfi C; Caruso R; Franzè E; Rizzo A; Rotondi A; Monteleone I; Fantini MC; Pallone F; Monteleone G
    Mol Cancer Ther; 2011 Oct; 10(10):1969-81. PubMed ID: 21817114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-gout agent allopurinol exerts cytotoxicity to human hormone-refractory prostate cancer cells in combination with tumor necrosis factor-related apoptosis-inducing ligand.
    Yasuda T; Yoshida T; Goda AE; Horinaka M; Yano K; Shiraishi T; Wakada M; Mizutani Y; Miki T; Sakai T
    Mol Cancer Res; 2008 Dec; 6(12):1852-60. PubMed ID: 19074830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YM155 sensitizes triple-negative breast cancer to membrane-bound TRAIL through p38 MAPK- and CHOP-mediated DR5 upregulation.
    Pennati M; Sbarra S; De Cesare M; Lopergolo A; Locatelli SL; Campi E; Daidone MG; Carlo-Stella C; Gianni AM; Zaffaroni N
    Int J Cancer; 2015 Jan; 136(2):299-309. PubMed ID: 24866585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
    Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
    Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAAD-cyclopamine augmented TRAIL-mediated apoptosis in malignant glioma cells by modulating the intrinsic and extrinsic apoptotic pathway.
    Siegelin MD; Siegelin Y; Habel A; Rami A; Gaiser T
    Neurobiol Dis; 2009 May; 34(2):259-66. PubMed ID: 19385057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decursin enhances TRAIL-induced apoptosis through oxidative stress mediated- endoplasmic reticulum stress signalling in non-small cell lung cancers.
    Kim J; Yun M; Kim EO; Jung DB; Won G; Kim B; Jung JH; Kim SH
    Br J Pharmacol; 2016 Mar; 173(6):1033-44. PubMed ID: 26661339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.